OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2020-09-30-accounts

Registered number: 08229467 Charity number: 1152591

HAEUK

(A company limited by guarantee)

UNAUDITED

TRUSTEES' REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 SEPTEMBER 2020

HAEUK

(A company limited by guarantee)

CONTENTS

Page
Reference and administrative details of the company, its Trustees and advisers 1
Trustees' report 2 - 6
Independent examiner's report 7
Statement of financial activities 8
Balance sheet 9 - 10
Notes to the financial statements 11 - 20

HAEUK

(A company limited by guarantee)

REFERENCE AND ADMINISTRATIVE DETAILS OF THE COMPANY, ITS TRUSTEES AND ADVISERS FOR THE YEAR ENDED 30 SEPTEMBER 2020

Trustees

Ann Marie Harding, Chairman Rosemary Frances Joseph, Treasurer Dr Timothy Crouch, Trustee Barrie Sidney Hurley, Trustee Samantha Jane Oxley, Treasurer (resigned 28 January 2021) Thomas Oliver Pickering, Trustee (resigned 28 January 2021) Edward George Thomas Price, Trustee Dana Shapiro, Trustee

Company registered number

08229467

Charity registered number

1152591

Registered office

2 Sheridan Close Bridgwater Somerset TA6 5SN

Accountants

Brian Cook Associates Chartered Tax Advisers and Accountants Marine House 151 Western Road Haywards Heath West Sussex RH16 3LH

Page 1

HAEUK

(A company limited by guarantee)

TRUSTEES' REPORT FOR THE YEAR ENDED 30 SEPTEMBER 2020

The Trustees present their annual report together with the financial statements of the company for 1 October 2019 to 30 September 2020. The Annual report serves the purposes of both a Trustees' report and a directors' report under company law. The Trustees confirm that the Annual report and financial statements of the charitable company comply with the current statutory requirements, the requirements of the charitable company's governing document and the provisions of the Statement of Recommended Practice (SORP) applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) (effective 1 January 2019).

Since the company qualifies as small under section 382 of the Companies Act 2006, the Strategic report required of medium and large companies under the Companies Act 2006 (Strategic Report and Directors' Report) Regulations 2013 has been omitted.

Objectives and activities

a. Policies and objectives

The main purpose of the charity is to promote and protect the physical and mental health of sufferers of Hereditary Angioedema in the United Kingdom through the provision of support, education and practical advice and to advance the education of the general public in all areas of the condition.

In setting objectives and planning for activities, the Trustees have given due consideration to general guidance published by the Charity Commission relating to public benefit, including the guidance 'Public benefit: running a charity (PB2)'.

b. Activities undertaken to achieve objectives

HAEUK has identified the following activities to promote the achievement of its objectives:

Page 2

HAEUK

(A company limited by guarantee)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 30 SEPTEMBER 2020

Achievements and performance

a. Review of activities

HAEUK was incorporated on 26th September 2012 and registered as a charity in England and Wales on 25 June 2013. It has more than 680 patients on its database and continues to provide information, advocacy and support to both them and newly diagnosed patients through its website, through patient contact over the telephone and by providing speakers to attend patient days at individual hospitals. Patients continue to value the opportunity to share their experiences via the confidential Facebook page.

Various policies and publications were produced/updated, including the availability of HAE A&E Cards for individual patients, updating patient literature to reflect developments in treatment, revisions and additions to the website, publication of regular newsletters, regular engagement with patients via social medi etc.

The HAEUK Annual Patient Day 2019 was held in Manchester on 23rd November 2019 with around 100 people attending, including consultant immunologists and specialist nurses,The presenters were drawn mainly from the local Immunology Centres, but also some of our Medical Advisory Panel assisted. Presentations included the optimum management of HAE, home therapy and quality of life issues, as well as a forum for patients to discuss current issues around their personal HAE management plans.

HAE UK Annual Scottish Patient Day 2019 was held in Glasgow on 2nd November 2019. More than 50 delegates attended, together with consultant immunologists and specialist nurses. There were presentations covering a range of treatment issues, as well as a number of patient stories.

HAEUK was represented at the UK PIN Conference held in Liverpool, but sadly the usual conferences planned for in 2020 were cancelled owing to Covid 19, including the biennial HAE International Conference. This was however replaced with a very successful ‘virtual’ conference.

The HAEUK 'Youth Ambassadors’ assisted at the Patient Day by running specific workshops for young members, and also maintained contact with younger members via Facebook, Whatsapp etc.

COVID response

The Covid 19 pandemic and subsequent ‘lockdowns’ caused us to have to redress our plans for face-to-face meetings and activities. Our first task was to inform and reassure patients with advice from the Medical Advisory Panel and the HAE Clinical Network which we kept updated as more information about the virus became available. Fortunately, the advice was that those with HAE (and no other underlying conditions) were no more liable to contract Coronavirus, nor to have worse outcomes if they did contract it, than people who do not have HAE. We kept our members informed by email, our social media channels and publishing updates on a dedicated page on our website.

In order to keep in contact with patients and to attempt to raise morale, we took out a Zoom contract and have run various virtual meetings ranging from fun quizzes to presentations by some of our clinicians. For HAE Day we ran a fancy dress competition and we also had competitions for younger members.

We have also maintained the 24/7 help line and provided advice and information via phone, e-mail and social media

HAEUK works closely with Genetic Alliance and Rare Disease UK in maintaining a top-level dialogue with the Department of Health. In this context, the Chief Executive Officer continued to work with health care professionals in the NHS, nationally and locally, to facilitate the wellbeing of patients and their continued access to appropriate medication. HAE UK also provided input to NICE and the Scottis Medicines Consortium in order to inform the eventual addition of a new medication, lanadelumab, to the commissioned and funded treatments available for treatment of HAE.

Page 3

(A company limited by guarantee)

HAEUK

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 30 SEPTEMBER 2020

Achievements and performance (continued)

The Executive Officer continued to maintain the Google Drive secure data storage/filing system to facilitate the safe keeping of policies, minutes and other documentation.

A comprehensive update of the HAE UK website was completed in 2018 to help better present information about Hereditary Angioedema and this has been under continual review and editing.

HAE UK is a member of HAE International and the Executive Officer is a member of the Board of Directors for HAEi. HAE UK participated in International HAE Awareness Day on 16th May 2020 by encouraging members to take part in the HAEi global walk and sharing a selfie of themselves walking on social media with the hashtag #7daysofhae. We also held ‘Silly Saturday’ with members sharing photos of themselves wearing creative or silly clothes or a hat, to show each other having fun during the difficult time. On the Saturday evening we also held a quiz via zoom, with individuals and family groups taking part. These activities helped us to stay connected with the wider HAE community and to raise awareness generally..

b. Fundraising activities and income generation

The primary source of income remains donations from pharmaceutical companies following submission of the necessary business plans to them. Individual members have undertaken fundraising activities of their own.

Financial review

a. Going concern

After making appropriate enquiries, the Trustees have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the financial statements. Further details regarding the adoption of the going concern basis can be found in the accounting policies.

b. Principal funding

Donations from pharmaceutical companies remain the primary source of funding.

Structure, governance and management

a. Constitution

HAEUK is registered as a charitable company limited by guarantee and was set up by a Memorandum of Association.

It is exempt from the use of the word 'limited'.

b. Methods of appointment or election of Trustees

The management of the company is the responsibility of the Trustees who are elected and co-opted under the terms of the Articles of Association.

Page 4

(A company limited by guarantee)

HAEUK

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 30 SEPTEMBER 2020

Plans for future periods

HAEUK will continue to encourage patients and the public to fundraise, through JustGiving or other means, eg, donations, sponsorship, regular/payroll giving, in order to broaden the scope of its funding sources.

HAEUK will continue to update/produce a range of policies to formalise its operating arrangements. The feasibility of funding research projects for the benefit of patients will be investigated.

The Youth Ambassador will continue to assist HAEUK to focus more on the needs of children and young people, including meetings and producing appropriate literature for schools, travel, etc.

HAEUK will continue to expand its influence and support to patients in Scotland and other parts of the United Kingdom.

There have been some benefits from the Coronavirus pandemic in that we have improved our virtual comms and these will be maintained as a valuable addition to our services to patients.

Members' liability

The Members of the company guarantee to contribute an amount not exceeding £1 to the assets of the company in the event of winding up.

Page 5

(A company limited by guarantee)

HAEUK

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 30 SEPTEMBER 2020

Statement of Trustees' responsibilities

The Trustees (who are also the directors of the company for the purposes of company law) are responsible for preparing the Trustees' report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company law requires the Trustees to prepare financial statements for each financial year. Under company law, the Trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of its incoming resources and application of resources, including its income and expenditure, for that period. In preparing these financial statements, the Trustees are required to:

The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Approved by order of the members of the board of Trustees on 24 June 2021 and signed on their behalf by:

Ann Marie Harding Chairman

Page 6

(A company limited by guarantee)

HAEUK

INDEPENDENT EXAMINER'S REPORT FOR THE YEAR ENDED 30 SEPTEMBER 2020

Independent examiner's report to the Trustees of HAEUK ('the company')

I report to the charity Trustees on my examination of the accounts of the company for the year ended 30 September 2020.

Responsibilities and basis of report

As the Trustees of the company (and its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act').

Having satisfied myself that the accounts of the company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of the company's accounts carried out under section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.

Independent examiner's statement

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:

  1. accounting records were not kept in respect of the company as required by section 386 of the 2006 Act; or

  2. the accounts do not accord with those records; or

  3. the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a 'true and fair' view which is not a matter considered as part of an independent examination; or

  4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities [applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)].

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

This report is made solely to the company's Trustees, as a body, in accordance with Part 4 of the Charities (Accounts and Reports) Regulations 2008. My work has been undertaken so that I might state to the company's Trustees those matters I am required to state to them in an Independent examiner's report and for no other purpose. To the fullest extent permitted by law, I do not accept or assume responsibility to anyone other than the company and the company's Trustees as a body, for my work or for this report.

Signed: Dated: 28 June 2021 Brian T Cook FCA

Brian Cook Associates

Chartered Tax Advisers and Accountants Marine House 151 Western Road Haywards Heath West Sussex RH16 3LH

Page 7

(A company limited by guarantee)

HAEUK

STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING INCOME AND EXPENDITURE ACCOUNT) FOR THE YEAR ENDED 30 SEPTEMBER 2020

Note
Income from:
Donations and legacies
3
Other trading activities
4
Total income
Expenditure on:
Raising funds
5
Charitable activities
7
Total expenditure
Net movement in funds
Reconciliation of funds:
Total funds brought forward
Net movement in funds
Total funds carried forward		 Unrestricted
funds
2020
£
57,169
746
57,915
-
76,433
76,433
(18,518)
162,310
(18,518)
143,792		 Total
funds
2020
£
57,169
746
57,915
-
76,433
76,433
(18,518)
162,310
(18,518)
143,792		 Total
funds
2019
£
77,145
-
77,145
152
78,003
78,155
(1,010)
163,320
(1,010)
162,310

The Statement of financial activities includes all gains and losses recognised in the year.

The notes on pages 11 to 20 form part of these financial statements.

Page 8

HAEUK (A company limited by guarantee) REGISTERED NUMBER: 08229467

BALANCE SHEET AS AT 30 SEPTEMBER 2020

Note
Fixed assets
Tangible assets
11
Current assets
Debtors
12
Cash at bank and in hand
Creditors: amounts falling due within one
year
13
Net current assets
Total assets less current liabilities
Total net assets
Charity funds
Restricted funds
15
Unrestricted funds
15
Total funds		 -
145,878
145,878
(4,739)		 2020
£
2,653
2,653
141,139
143,792
143,792
-
143,792
143,792		 700
163,405
164,105
(4,043)		 2019
£
2,248
2,248
160,062
162,310
162,310
-
162,310
162,310

Page 9

HAEUK

(A company limited by guarantee) REGISTERED NUMBER: 08229467

BALANCE SHEET (CONTINUED) AS AT 30 SEPTEMBER 2020

The company was entitled to exemption from audit under section 477 of the Companies Act 2006.

The members have not required the company to obtain an audit for the year in question in accordance with section 476 of Companies Act 2006.

The Trustees acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to entities subject to the small companies regime.

The financial statements were approved and authorised for issue by the Trustees on 24 June 2021 and signed on their behalf by:

Ann Marie Harding

Chairman

The notes on pages 11 to 20 form part of these financial statements.

Page 10

HAEUK

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2020

1. General information

HAEUK is a private company, limited by guarantee, domiciled in England and Wales, registration number 08229467. The registered charity number is 1152591. The registered office of the company is 2 Sheridan Close, Bridgwater, Somerset, TA6 5SN.

2. Accounting policies

2.1 Basis of preparation of financial statements

The financial statements have been prepared in accordance with the Charities SORP (FRS 102) - Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.

HAEUK meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy.

2.2 Income

All income is recognised once the company has entitlement to the income, it is probable that the income will be received and the amount of income receivable can be measured reliably.

2.3 Expenditure

Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is classified by activity.

Expenditure is accounted for on an accruals basis and has been included under expense categories that aggregate all costs for allocation to activities.

Expenditure on raising funds includes all expenditure incurred by the company to raise funds for its charitable purposes and includes costs of all fundraising activities events and non-charitable trading.

Expenditure on charitable activities is incurred on directly undertaking the activities which further the company's objectives, as well as any associated support costs.

Grants payable are charged in the year when the offer is made except in those cases where the offer is conditional, such grants being recognised as expenditure when the conditions attaching are fulfilled. Grants offered subject to conditions which have not been met at the year end are noted as a commitment, but not accrued as expenditure.

All expenditure is inclusive of irrecoverable VAT.

Page 11

HAEUK

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2020

2. Accounting policies (continued)

2.4 Tangible fixed assets and depreciation

Tangible fixed assets costing £NIL or more are capitalised and recognised when future economic benefits are probable and the cost or value of the asset can be measured reliably.

Tangible fixed assets are initially recognised at cost. After recognition, under the cost model, tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. All costs incurred to bring a tangible fixed asset into its intended working condition should be included in the measurement of cost.

Depreciation is charged so as to allocate the cost of tangible fixed assets less their residual value over their estimated useful lives, on a reducing balance basis.

Depreciation is provided on the following basis:

Office equipment - 20%

2.5 Debtors

Trade and other debtors are recognised at the settlement amount after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.

2.6 Cash at bank and in hand

Cash at bank and in hand includes cash and short-term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.

2.7 Liabilities and provisions

Liabilities are recognised when there is an obligation at the Balance sheet date as a result of a past event, it is probable that a transfer of economic benefit will be required in settlement, and the amount of the settlement can be estimated reliably.

Liabilities are recognised at the amount that the company anticipates it will pay to settle the debt or the amount it has received as advanced payments for the goods or services it must provide.

Provisions are measured at the best estimate of the amounts required to settle the obligation. Where the effect of the time value of money is material, the provision is based on the present value of those amounts, discounted at the pre-tax discount rate that reflects the risks specific to the liability. The unwinding of the discount is recognised in the Statement of financial activities as a finance cost.

2.8 Financial instruments

The company only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value with the exception of bank loans which are subsequently measured at amortised cost using the effective interest method.

Page 12

(A company limited by guarantee)

HAEUK

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2020

2. Accounting policies (continued)

2.9 Fund accounting

General funds are unrestricted funds which are available for use at the discretion of the Trustees in furtherance of the general objectives of the company and which have not been designated for other purposes.

3. Income from donations and legacies

Unrestricted
funds
2020
£
Donations
CSL Behring
35,000
Shire Pharamaceutical
13,020
BioCryst Pharmaceuticals
3,000
Oracle Fieldwork
1,400
Pharming Pharmaceuticals
-
Subtotal detailed disclosure
52,420
Donations
4,749
Total 2020
57,169
Total 2019
77,145		 Total
funds
2020
£
35,000
13,020
3,000
1,400
-
52,420
4,749
57,169
77,145		 Total
funds
2019
£
35,000
-
-
-
35,000
70,000
7,145
77,145

4. Income from other trading activities

Income from fundraising events

Unrestricted Total Total
funds funds funds
2020 2020 2019
£ £ £
Fun day raffle 746 746 -

Page 13

HAEUK

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2020

5. Expenditure on raising funds Costs of raising voluntary income

Unrestricted
funds
2020
£
Manchester 10k run fees
-
Total 2019
152
6.
Analysis of grants
Grants to
Institutions
2020
£
Grants paid
-
7.
Analysis of expenditure on charitable activities
Summary by fund type
Unrestricted
funds
2020
£
Support and education to help sufferers of Hereditary
Angioedema in the UK
76,433
Total 2019
78,003		 Total
funds
2020
£
-
152
Total
funds
2020
£
-
Total
funds
2020
£
76,433
78,003		 Total
funds
2019
£
152
Total
funds
2019
£
7,500
Total
funds
2019
£
78,003

Page 14

(A company limited by guarantee)

HAEUK

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2020

8. Analysis of expenditure by activities

Support and education to help
sufferers of Hereditary
Angioedema in the UK
Total 2019
Analysis of direct costs
Manchester patient day
Book commission
Nurses education programme
Glasgow patient day
Edinburgh patient day
Farnborough patient day
Drayton Park patient day
Virtual patient day
UK Healthcare Expo
Total 2020
Total 2019		 Activities
undertaken
directly
2020
£
20,329
19,031		 Grant
funding of
activities
2020
£
-
7,500		 Support
costs
2020
£
56,103
51,472
Activities
2020
£
5,628
-
11,352
1,500
-
-
-
1,375
474
20,329
19,031		 Total
funds
2020
£
76,432
78,003
Total
funds
2020
£
5,628
-
11,352
1,500
-
-
-
1,375
474
20,329
19,031		 Total
funds
2019
£
78,003
Total
funds
2019
£
-
1,200
8,844
-
2,660
3,924
2,403
-
-
19,031

Page 15

HAEUK

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2020

8. Analysis of expenditure by activities (continued)

Analysis of support costs

Activities
2020
£
Depreciation
663
Communication costs
388
Website costs
360
Postage, printing and stationery
992
Travel and subsistence
2,806
Subscription costs
266
CEO consultancy fees
32,250
EO consultancy fees
13,273
Sundry expenses
529
Hoodies, T shirts, wristbands
20
Insurance
280
Accountancy fees
996
Film production
-
IT software and consumables
2,272
Research costs
-
Trustees' expenses reimbursed
959
Bank fees
49
Total 2020
56,103
Total 2019
51,472
9.
Independent examiner's remuneration
Fees payable to the company's independent examiner for the independent
examination of the company's annual accounts
Fees payable to the company's independent examiner in respect of:
All other services not included above		 Total
funds
2020
£
663
388
360
992
2,806
266
32,250
13,273
529
20
280
996
-
2,272
-
959
49
56,103
51,472
2020
£
780
48		 Total
funds
2019
£
562
532
118
2,018
2,345
216
28,800
11,500
690
431
280
1,058
950
557
460
955
-
51,472
2019
£
780
48

Page 16

HAEUK

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2020

10. Trustees' remuneration and expenses

During the year, no Trustees received any remuneration or other benefits (2019 - £NIL) .

During the year ended 30 September 2020, expenses totalling £ 959 were reimbursed or paid directly to 7 Trustees (2019 - £955 to 6 Trustees) . The expenses related to travel costs.

11. Tangible fixed assets

Cost or valuation
At 1 October 2019
Additions
At 30 September 2020
Depreciation
At 1 October 2019
Charge for the year
At 30 September 2020
Net book value
At 30 September 2020
At 30 September 2019
12.
Debtors
Due within one year
Prepayments and accrued income		 2020
£
-
-		 Office
equipment
£
5,856
1,068
6,924
3,608
663
4,271
2,653
2,248
2019
£
700
700

Page 17

(A company limited by guarantee)

HAEUK

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2020

13. Creditors: Amounts falling due within one year

2020 2019
£ £
Accruals and deferred income 4,739 4,043

14. Financial instruments

Financial assets
Financial assets measured at amortised cost
Financial liabilities
Financial liabilities measured at amortised cost		 2020
£
145,878
2020
£
(4,739)		 2019
£
163,405
2019
£
(4,043)

Financial assets measured at amortised cost comprises cash at bank and in hand.

Financial liabilities measured at amortised cost comprises accruals.

Page 18

(A company limited by guarantee)

HAEUK

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2020

15. Statement of funds

Statement of funds - current year
Unrestricted funds
General Funds
Statement of funds - prior year
Unrestricted funds
General Funds		 Balance at 1
October
2019
£
162,310
Balance at
1 October
2018
£
163,320		 Income
£
57,915
Income
£
77,145		 Expenditure
£
(76,433)
Expenditure
£
(78,155)		 Balance at
30
September
2020
£
143,792
Balance at
30
September
2019
£
162,310

Page 19

HAEUK

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2020

16. Analysis of net assets between funds

Analysis of net assets between funds - current period

Unrestricted
funds
2020
£
Tangible fixed assets
2,653
Current assets
145,878
Creditors due within one year
(4,739)
Total
143,792		 Total
funds
2020
£
2,653
145,878
(4,739)
143,792

Analysis of net assets between funds - prior period

Tangible fixed assets
Current assets
Creditors due within one year
Total		 Unrestricted
funds
2019
£
2,248
164,104
(4,043)
162,309		 Total
funds
2019
£
2,248
164,104
(4,043)
162,309

Page 20